Thursday Jul 10
New medication shows promise in treating common skin disease
An investigational medication shows promise in treating the most common skin disorder, often referred to as eczema or atopic dermatitis, according to a study published July 9 in the New England Journal of Medicine .
Press Digest- New York Times business news - July 10
The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.
The Washington Post
Sanofi Plans Final Tests as Regeneron Drug Cuts Eczema Symptoms
Sanofi and Regeneron Pharmaceuticals Inc. said they plan to test their experimental eczema treatment in large late-stage studies after a smaller trial reduced symptoms of the scaly, itching disease.
Sanofi-Regeneron drug tames eczema in study
An experimental drug from Sanofi and Regeneron Pharmaceuticals Inc significantly reduced skin lesions and itching in adult patients with atopic dermatitis, a chronic form of eczema that is poorly controlled by standard drugs, the companies said on Wednesday.
Wet wraps to treat eczema?
A study conducted by experts at National Jewish Health in Denver shows wet wrap therapy vastly improves symptoms of eczema and atopic dermatitis in children.
The Star Online
Occasionally, jewellery may also cause an allergic skin reaction due to the nickel content in the metal that comes into direct contact with the skin.